(Q41214699)

28 September 2017

Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells (English)

1 reference

28 September 2017

Mal A

1

1 reference

28 September 2017

Poon RY

2

1 reference

28 September 2017

Howe PH

3

1 reference

28 September 2017

Toyoshima H

4

1 reference

28 September 2017

Hunter T

5

1 reference

28 September 2017

Harter ML

6

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

28 September 2017

1 reference

28 September 2017

380

1 reference

28 September 2017

262-265

1 reference

28 September 2017

6571

1 reference

https://scigraph.springernature.com/pub.10.1038/380262a0

28 September 2017

0 references

cites work

Transforming growth factor beta 1 (TGF beta 1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity

1 reference

7 January 2021

TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.

1 reference

7 January 2021

Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest

1 reference

7 January 2021

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta

1 reference

7 January 2021

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

1 reference

7 January 2021

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

1 reference

7 January 2021

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

1 reference

7 January 2021

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

1 reference

7 January 2021

The adenovirus E1A 243R protein purified from Escherichia coli under nondenaturing conditions is found in association with dnaK

1 reference

7 January 2021

A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells

1 reference

7 January 2021

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

7 January 2021

Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products

1 reference

7 January 2021

Adenoviral ElA-associated protein p300 as a functional homologue of the transcriptional co-activator CBP

1 reference

7 January 2021

Disruption of cell-cycle control by viral oncoproteins

1 reference

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

7 January 2021

G1 phase progression: cycling on cue

1 reference

7 January 2021

1 reference

7 January 2021

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

1 reference

7 January 2021

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest

1 reference

7 January 2021

The adenovirus E1A protein overrides the requirement for cellular ras in initiating DNA synthesis.

1 reference

7 January 2021

The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2.

1 reference

7 January 2021

Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin

1 reference

7 January 2021

1 reference

7 January 2021

Identifiers

DOI

10.1038/380262A0

1 reference

Dimensions Publication ID

28 September 2017

0 references

1 reference